[1]
OLA SAYED M. ALI et al. 2017. Assessment of circulating fibroblast growth factor 23 in type 2 diabetic patients with nephropathy. International Journal of Pharma and Bio Sciences. 8, 3 (Sep. 2017), 239–246. DOI:https://doi.org/10.22376/ijpbs.2017.8.3.b239-246.